Invictus MD Provides an Update on Harvest by Acreage Pharms Ltd.     PRESS RELEASE INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that its wholly owned subsidiary, Acreage Pharms Ltd. (“Acreage Pharms”), a licensed producer under the Access to Cannabis for Medical Purposes
Complete Reading

Invictus MD Announces Inclusion on Horizons Marijuana Life Sciences Index ETF     BUZ INVESTORS PRESS RELEASE  Invictus MD Announces Inclusion  INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce its inclusion in the Horizon Medical Marijuana Life Sciences ETF (TSX:HMMJ) (“HMMJ ETF”), which is
Complete Reading

Invictus MD Closes $25,008,750 Bought Deal Private Placement Private Placement BUZ INVESTORS PRESS RELEASE Private Placement   INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that it has closed its previously announced bought deal private placement (the “Offering”), with Canaccord Genuity Corp., Eventus Capital
Complete Reading

Invictus MD announces $20,000,000 Bought Deal Private Placement of Units     BUZINVESTORS PRESS RELEASE Invictus MD announces   INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) announces it has determined not to proceed with its previously announced offering of convertible debentures as set forth in a news release
Complete Reading

Chart | Calendar   | TRADE NOW | CANNABIS Invictus MD to Open the Market at TSX Venture Exchange on May 5 BUZ INVESTORS PRESS RELEASE  Invictus MD to Open the Market  INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) Invictus MD is pleased to announce that its management team will
Complete Reading

Create Account



Log In Your Account



Dash_En